LALPATHLABNSEJanuary 27, 2023

Dr. Lal Path Labs Ltd.

802words
2turns
0analyst exchanges
3executives
Management on call
Om Prakash Manchanda
Managing Director, Mr. Bharath U –
Ved Prakash Goel
Group Chief Financial Officer, Mr. Shankha
Rajat Kalra
Company Secretary
Key numbers — 5 extracted
rs,
or, please register at the below mentioned link. Pre-registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial int
49.7 million
PSCs) and 10,599 Pick-up Points (PUPs). In FY21 & FY22, DLPL collected and processed approximately 49.7 million samples and 66 million samples from approximately 20.3 million and 27.3 million patients, respecti
66 million
Points (PUPs). In FY21 & FY22, DLPL collected and processed approximately 49.7 million samples and 66 million samples from approximately 20.3 million and 27.3 million patients, respectively. Additional infor
20.3 million
llected and processed approximately 49.7 million samples and 66 million samples from approximately 20.3 million and 27.3 million patients, respectively. Additional information on Dr. Lal PathLabs Limited: Cor
27.3 million
ssed approximately 49.7 million samples and 66 million samples from approximately 20.3 million and 27.3 million patients, respectively. Additional information on Dr. Lal PathLabs Limited: Corporate Identifica
Advertisement
Speaking time
Details of the conference call are as follows
1
Additional information on Dr. Lal PathLabs Limited
1
Opening remarks
Details of the conference call are as follows
Time ● 5:00pm IST on Thursday, February 2, 2023 To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link. Pre-registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call. Universal Access Conference dial-in International Toll Number ● +91 22 6280 1141 ● +91 22 7115 8042 ● USA – 18667462133 ● UK – 08081011573 ● Singapore – 8001012045 ● Hong Kong – 800964448 Replay ● Dial in No. +91 22 7194 5757 ● 52223 (passcode) ● Valid from Feb 2, 2023 to Feb 9, 2023 -ENDS- Corporate Office: Dr. Lal PathLabs Ltd., 12th Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 39835050. E-mail:
Additional information on Dr. Lal PathLabs Limited
Corporate Identification No: L74899DL1995PLC065388 Website: https://www.lalpathlabs.com/ For further information, please contact: Ved Goel / Rajat Kalra Dr. Lal PathLabs Limited E-mail:ved.goel@lalpathlabs.com rajat.kalra@lalpathlabs.com Siddharth Rangnekar / Nishid Solanki CDR India Email: siddharth@cdr-india.com nishid@cdr-india.com Disclaimer: Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like Government actions, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Dr. Lal PathLabs Limited will not be in any way responsible for any action taken based on such statements and discussions and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent even
Advertisement
← All transcriptsLALPATHLAB stock page →